Tag Archives: sanofi aventis

Featured Stories

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Yet another study is confirming the association between the diabetes drug, Actos, and bladder cancer. This latest research, published today in the Canadian Medical Association Journal, found that taking Actos raised the risk of bladder cancer among diabetics by about one-fifth.

Read More

Tentative Ohio Fracking Regulations Criticized as too Lax

Lawmakers in Ohio have tentatively passed new regulations governing hydraulic fracturing (fracking) drilling but they’ve immediately been criticized for being too favorable to the natural gas and oil industries.

Read More

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

A newly published metal-on-metal hip replacement study is reporting that the majority of failures occur early, within two years of surgery. The study, published in the journal Orthopedics, is just the latest to indicate that close follow-up of metal-on-metal hip implant patients is warranted.

Read More

Lawsuits over DePuy ASR Metal-on-Metal Hip Implants Continue to Mount

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be hit with lawsuits over recalled metal-on-metal DePuy ASR hip implants. Just yesterday, the national law firm of Parker Waichman LLP announced it had filed yet another DePuy ASR hip implant lawsuit, this time on behalf of a Virginia resident ...

Read More

Tennessee Resident Files Pradaxa Bleeding Lawsuit Following Cerebral Hemorrhage

A man from Tennessee has filed a lawsuit against the maker of Pradaxa, claiming that the blood thinner caused him to suffer a cerebral hemorrhage. The complaint alleges Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause Serious, life-threatening bleeds, and did not warn that Pradaxa bleeding side effects ...

Read More

Hip Replacement, Knee Implant Patients with Diabetes, Other Health Problems May Face Difficult Recoveries

Patients receiving hip replacement devices or knee implants may face a more complicated recovery if they are obese, or suffer from diabetes or other health woes. According to a new study published online in the journal Anesthesiology, at least 3% of all total hip or knee replacement patients will ...

Read More

Three Injured, Long Island Railroad Train Hits Car on Tracks

Three Injured When Long Island Railroad Train Hits Car on Tracks

Three people, including a train engineer, were injured on Wednesday when a Long Island Rail Road train hit a livery cab on the tracks west of Wyandanch station, LIRR officials said. LIRR spokesman Salvatore Arena said the driver of the Lincoln Town Car was taken to Good Samaritan Hospital Medical Center ...

Read More

Johnson & Johnson’s Ethicon Division to End Sales of Gynecare Prolift, Three Other Transvaginal Mesh Devices

Johnson & Johnson’s Ethicon Inc. division revealed yesterday that it will end sales of its Gynecare Prolift device and three other transvaginal mesh products. The plan to stop selling the four products was set forth in a letter filed by the company in the Ethicon transvaginal mesh multidistrict litigation ...

Read More

Metal-on-Metal Hip Replacement Device

Smith & Nephew’s Birmingham Metal-on-Metal Hip Replacement Device

Wright Medical Inc. took steps in to 2006 to convince the U.S. Food & Drug Administration (FDA) to reject pre-market approval of rival Smith & Nephew’s Birmingham metal-on-metal hip implant. Wright Medical, which makes two metal-on-metal hip replacement devices, the Conserve and the Lieneage device, filed a citizen petition ...

Read More

Woman Alleges Permanent Alopecia after Using Taxotere Chemotherapy Drug

Woman Alleges Permanent Alopecia after Using Taxotere

Sanofi-Aventis is facing another lawsuit over its chemotherapy drug, Taxotere. A woman alleges that the company failed to warn about the risk of permanent alopecia, or hair loss, after taking Taxotere. She alleges that the company misled her and her … Continue reading

Posted in Pharmaceuticals, Taxotere | Tagged , , , , |

New Mexico AG Files Lawsuit Against Plavix Manufacturers

New Mexico AG Files Lawsuit Against Plavix Manufacturers

The New Mexico Attorney General has filed a lawsuit against Bristol-Myers Squibb, the manufacturer of Plavix, alleging that the company failed to warn of risks associated with the blood thinner. The suit alleges that the pharmaceutical giant deceived New Mexicans … Continue reading

Posted in Pharmaceuticals, Plavix | Tagged , , , , , , |

Sanofi Faces Another Lawsuit over Taxotere

Sanofi Faces Another Lawsuit over Taxotere

Sanofi-Aventis faces another lawsuit alleging that its chemotherapy drug Taxotere led to permanent hair loss, or alopecia. The suit accuses the drug maker of failing to adequately warn about the risk of irreversible hair loss. The plaintiff is a California … Continue reading

Posted in Pharmaceuticals, Taxotere | Tagged , , , , , , , , , , , , |

Taxotere and the Risk of Alopecia

Taxotere and the Risk of Alopecia

The U.S. Food and Drug Administration (FDA) approved Taxotere as a chemotherapy drug in 1996. Taxotere is manufactured by Sanofi-Aventis and is commonly used to treat breast cancer, as well as other cancers. Some patients taking Taxotere have reported experiencing … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , , , , , , , , , |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.